契約負債、研究開発費、純資産の部合計
- 【期間】
| 年度 | 契約負債 | 研究開発費 | 純資産の部合計 |
|---|
| 2007/03 | - | | - | | 372億 | |
| 2008/03 | - | | - | | 381億 | +2.3% |
| 2009/03 | - | | - | | 318億 | -16.4% |
| 2010/03 | - | | - | | 326億 | +2.3% |
| 2011/03 | - | | - | | 323億 | -0.9% |
| 2012/03 | - | | - | | 315億 | -2.3% |
| 2013/03 | - | | 17.9億 | | 345億 | +9.5% |
| 2014/03 | - | | 19.1億 | +6.6% | 366億 | +6.1% |
| 2015/03 | - | | 20.8億 | +8.8% | 325億 | -11.4% |
| 2016/03 | - | | 18.2億 | -12.6% | 304億 | -6.4% |
| 2017/03 | - | | 17.4億 | -4.4% | 312億 | +2.9% |
| 2018/03 | - | | 18.3億 | +5% | 309億 | -1.1% |
| 2019/03 | - | | 17.2億 | -6% | 306億 | -1% |
| 2020/03 | - | | 19.1億 | +11.1% | 302億 | -1.3% |
| 2021/03 | - | | 20.5億 | +7.4% | 338億 | +11.9% |
| 2022/03 | 0.81百万 | | 21.7億 | +6% | 402億 | +19.1% |
| 2023/03 | 11,000 | -98.6% | 22.1億 | +1.5% | 432億 | +7.3% |
| 2024/03 | 79,000 | +618.2% | - | | 470億 | +9% |
